HSBC Holdings’s Quest Diagnostics DGX Stock Holding History

HSBC Holdings’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,300	Closed	-$1.97M	–	3095
2023 Q4	$1.97M	Hold	14,300	–	–	﹤0.01%	1502
2023 Q3	$1.76M	Hold	14,300	–	–	﹤0.01%	1505
2023 Q2	$2.02M	Hold	14,300	–	–	﹤0.01%	1434
2023 Q1	$1.99M	Buy	+14,300	New	+$2.05M	﹤0.01%	1517
2019 Q1	–	Sell	-1,600	Closed	-$133K	–	2736
2018 Q4	$133K	Buy	+1,600	New	+$150K	﹤0.01%	2524

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

HSBC Holdings's DGX Position: Q1 2026 in Review

HSBC Holdings reduced its Quest Diagnostics (DGX) stake by 14% in Q1 2026, selling an estimated $6.21M and leaving 195,144 shares worth $38.2M. The position accounts for 0.02% of the portfolio, ranked #584.

HSBC Holdings first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $96M in Q4 2022. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

HSBC Holdings held 195,144 shares of Quest Diagnostics worth $38.2M as of Q1 2026.
HSBC Holdings sold 31,963 Quest Diagnostics shares in Q1 2026, an estimated $6.21M.
Quest Diagnostics made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #584 holding.
HSBC Holdings first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's Quest Diagnostics position peaked at $96M in Q4 2022.
1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.